Amphastar Pharmaceuticals' IPO

Amphastar Pharmaceuticals raised a round of funding on June 25, 2014. Investors include Public.

Amphastar Pharmaceuticals is a specialty pharmaceutical company that is engaged in the development, manufacture and marketing of generic and proprietary injectable and inhalation products. Amphastar a…

Articles about Amphastar Pharmaceuticals' IPO: